Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > SAGE Sage Therapeutics > Detailed Quotes

SAGE Sage Therapeutics

37.670
-0.830-2.16%
Close 09/26 16:00 ET
High
39.230
Open
38.420
Turnover
9.75M
Low
37.560
Pre Close
38.500
Volume
256.98K
Market Cap
2.24B
P/E(TTM)
Loss
52wk High
47.750
Shares
59.42M
P/E(Static)
Loss
52wk Low
27.360
Float Cap
1.96B
Bid/Ask %
0.00%
Historical High
195.970
Shs Float
51.96M
Volume Ratio
0.70
Historical Low
24.250
Dividend TTM
--
Div Yield TTM
750
P/B
1.49
Dividend LFY
--
Div Yield LFY
1990.97%
Turnover Ratio
0.50%
Amplitude
4.34%
Avg Price
37.936
Lot Size
1
Float Cap
1.96B
Bid/Ask %
0.00%
Historical High
195.970
Shs Float
51.96M
Volume Ratio
0.70
Historical Low
24.250
Dividend TTM
--
P/B
1.49
Dividend LFY
--
Turnover Ratio
0.50%
Amplitude
4.34%
Avg Price
37.936
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel medicines. It targets diseases and disorders of the brain with three key focus areas: depression, neurology, and neuropsychiatry. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010, and is headquartered in Cambridge, MA.
CEO: Mr. Barry E. Greene
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...